NCT02859935 (SYNBASIN) is a NA clinical trial of Screening and feedback in Risk Behavior, sponsored by Public Health Service of Amsterdam.

Who is sponsoring NCT02859935?

NCT02859935 is sponsored by Public Health Service of Amsterdam.

What drugs are being tested in NCT02859935?

Interventions in NCT02859935: Screening and feedback.

What condition does NCT02859935 study?

NCT02859935 studies Risk Behavior.

Is NCT02859935 still recruiting?

NCT02859935 is currently completed. Last updated 22 January 2019.

Last reviewed 2019-01-22 · How we verify

NCT02859935: SYNBASIN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A SYNdemic BASed INtervention for MSM With High Risk Behavior: Design of a Randomized Controlled Trial

Completed NA Last updated 22 January 2019

What this trial tests

NA trial testing Screening and feedback in Risk Behavior in 150 participants. Completed in 1 September 2018.

Timeline

1 September 2016

Primary endpoint
1 September 2018

1 September 2018

Quick facts

Lead sponsor	Public Health Service of Amsterdam
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	150
Start date	1 September 2016
Primary completion	1 September 2018
Estimated completion	1 September 2018
Sites	1 location across Netherlands

Drugs / interventions tested

Screening and feedback

Conditions studied

Risk Behavior — all drugs for Risk Behavior →

Sponsor

Public Health Service of Amsterdam — full company profile →

Who can join

18 and older, male only, with Risk Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this randomized controlled intervention study at the STI outpatient clinic of Amsterdam is to answer the following questions : Does a personalised behaviour intervention comprising of targeted in-depth screening on mental health problems and drug use and, in case identified, subsequent linkage to care increase help seeking behaviour, and decrease risk behaviour in MSM who are at high risk for STIs and HIV?

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Enhancing help-seeking behaviour among men who have sex with men at risk for sexually transmitted infections: the syn.bas.in randomised controlled trial.
Achterbergh RCA, van Rooijen MS, van den Brink W, Boyd A, et al · · 2021 · cited 11× · PMID 32737210 · DOI 10.1136/sextrans-2020-054438
Design of a syndemic based intervention to facilitate care for men who have sex with men with high risk behaviour: the syn.bas.in randomized controlled trial.
Achterbergh RCA, van der Helm JJ, van den Brink W, de Vries HJC. · · 2017 · cited 9× · PMID 28587607 · DOI 10.1186/s12879-017-2474-x

Verify or expand the search:

Other recruiting trials for Risk Behavior

Currently open trials in the same condition.

NCT05522647 — Detection of Risk Behaviors: Pilot Observational Study With Bedridden and Agitated Patients. · recruiting
NCT07255300 — Follow up Study of Varapodio Trial: Effect of Longevity and Fasting Mimicking Diet on Risk Factors Age Correlated and Bi · NA · recruiting
NCT06311838 — Building Social and Structural Connections for the Prevention of Opioid Use Disorder Among Youth Experiencing Homelessne · NA · recruiting
NCT06105853 — Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder · NA · recruiting
NCT03337009 — The Impact of a Web-Based Naloxone Intervention Under Standing Orders to Patients Prescribed Chronic Opioid Therapy · NA · active not recruiting

Other Public Health Service of Amsterdam trials

Trials by the same sponsor.

NCT05998226 — VAT-2: Evaluation of a Virtual Antimicrobial Stewardship Team (VAT) on Antibiotic Prescriptions in Nursing Homes · NA · completed
NCT05567939 — Clinical, Virological, Immunological, Psychosocial and Epidemiological Consequences of Human Monkeypox Virus (ProMPX) · terminated
NCT05093036 — E-Health for Zero Infections - Facilitating Access to and Use of HIV Pre-Exposure Prophylaxis (PrEP) in the Netherlands · NA · completed
NCT03294395 — New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea · Phase 3 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02859935 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Public Health Service of Amsterdam
Last refreshed: 22 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02859935.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing